Among the signature genes, the over-expression of STK24 was linked to chemoresistance to all the studied drugs except Gefitinib in the lung cancer cell lines; whereas the over-expression of FAM14A was associated with chemosensitivity to all the studied drugs except Gefitinib in lung cancer cell lines. This evidence concerns the gene STK24 and lung carcinoma.